Factors Associated with HIV Status Disclosure and Its Effect on Treatment Adherence and Quality of Life among Children 6–17 Years on Antiretroviral Therapy in Southern Highlands Zone, Tanzania: Unmatched Case Control Study

Table 4

Relationship between HIV status disclosure and ART adherence, among children between 6 and 17 years on antiretroviral therapy, in Southern Highlands Zone, Tanzania (N=309).

Variable	ART adherence		P value
	Adherent; n (%)	Nonadherent; n (%)
Age of child:
6–9 years	3 (3.7)	79 (96.3)
10–13 years	7 (5.2)	127 (94.8)	0.063
14–17 years	11 (11.8)	82 (88.2)
HIV status disclosure:
No	19 (9.2)	188 (90.8)	<0.05
Yes	2 (2.0)	100 (98.0)
Child’s sex:
Male	10 (6.5)	144 (93.5)	0.833
Female	11(7.1)	144 (92.9)
Child/caregiver relationship:
Biological parents	9 (4.8)	180 (95.2)	0.075
Others	12 (10.0)	108 (90.0)
Caregiver income
Employment	7 (7.8)	83 (92.2)	0.660
Others	17 (6.4)	205 (93.6)
Ever hospitalized:
Yes	13 (6.4)	190 (93.6)	0.705
No	8 (7.5)	98 (92.5)
Child’s level of education:
Primary or less	15 (6.3)	223 (93.7)	0.528
Secondary or high	6 (8.5)	65 (91.5)
Caregiver level of education:
Primary or less	17 (7.7)	203 (92.3)	0.307
Secondary or high	4 (4.5)	85 (95.5)